HFEA/LinkedIn
Jun 18, 2026, 13:25
Zoe’s Experience Living With The Antiphospholipid Syndrome – HFEA
Human Fertilisation and Embryology Authority (HFEA) shared a post on LinkedIn:
”Antiphospholipid syndrome (APS) is a rare autoimmune disorder affecting around 1 in 2000 people in the UK. It increases the risk of blood clots in various parts of the body. In our latest blog, Zoe, a member of our Patient Engagement Forum, shares her experience living with the condition and the impact that it has had on her fertility journey.
Read Zoe’s blog.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jun 18, 2026, 14:26The Risks of Unregulated Sperm Donation – HFEA
-
Jun 18, 2026, 12:26Mark Your Calendars For RPLA’s 2nd Annual Walk/Run For Recurrent Pregnancy Loss Awareness – RPLA
-
Jun 18, 2026, 12:10HQIP Webinar Explores Maternity Inequalities During Clinical Audit Awareness Week – RCOG
-
Jun 18, 2026, 11:57ASRM Recognizes Rebecca Flick and Cindy Hollister for Their Advocacy in Infertility Care – ASRM
-
Jun 18, 2026, 11:47Fertility and Sterility On Air Hosts Fellow Debate on Gestational Carrier Use Without Medical Indication – Fertility and Sterility
-
Jun 18, 2026, 11:45FIGO, WHO and ICM Highlight Global Efforts to Implement New PPH Guidelines – FIGO
-
Jun 18, 2026, 11:13Romain Corroenne: Systematic Review Explores Diffusion Tensor Imaging in Spina Bifida and Prenatal Repair Era
-
Jun 18, 2026, 10:40UK Peers Call for Fertility Law Reform Following House of Lords Debates – Femtech World
-
Jun 18, 2026, 02:58Outstanding Challenges in Maternal–Perinatal Health – FIGO